Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards CIS-DDP resistance

Experimental Oncology

Volumn 29, Issue 3, 2007, Pages 197-202

  Pyaskovskaya, O N ^a   Dasyukevich, O I ^a   Kolesnik, D L ^a   Garmanchouk, L V ^a   Todor, I N ^a   Solyanik, G I ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

cis DDP resistance; Lewis lung carcinoma; VEGF

Indexed keywords

CISPLATIN; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; FEMALE; IN VITRO STUDY; LEWIS CARCINOMA; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36749100969     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1999; 267: 10931-4.
3. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, Iki M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996; 56: 2671-6.
4. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased scrum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001; 19: 577-83.
5. Rasila KK, Burger RA, Smith H, Lee FC, Verschraegen C. Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer 2005; 15: 710-26.
6. Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, Chen GH. Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 2006; 12: 7598-603.
7. Demirkesen C, Buyukpinarbasili N, Ramazanoglu R, Oguz O, Mandel NM, Kaner G. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor. Pathology 2006; 38: 132-7.
8. Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Clin Cancer Res 2007; 13: 76-80.
9. Hillen F, van de Winkel A, Creytens D, Vermeulen AH, Griffioen AW. Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma. Melanoma Res 2006; 16: 453-7.
10. Kurschat P, Eming S, Nashan D, Krieg T, Mauch C. Early increase in serum levels of the angiogenesis-inhibitorendostatin and of basic fibroblast growth factor in melanoma patients during disease progression. Br J Dermatol 2007; 156: 653-8.
11. Coomber BL, Yu JL, Fathers KE, Plumb C, Rak JW. Angiogenesis and the role of epigenetics in metastasis. Clin Exp Metastasis 2003; 20: 215-27.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assayas. J Immunol Methods 1983; 65: 55-63.
13. Kerbel RS. Growth dominance of the metastatic cancer cells: cellular and molecular aspects. Adv Cancer Res 1990; 55: 87-131.
14. Kolobov AV, Polezhaev AA, Solyanik GI. The role of cell motility in metastatic cell dominance phenomenon: analysis by a mathematical model. J Theor Med 2000; 3: 63-77.